PL367702A1 - Combination of a taxane and a cyclin-dependent kinase - Google Patents
Combination of a taxane and a cyclin-dependent kinaseInfo
- Publication number
- PL367702A1 PL367702A1 PL02367702A PL36770202A PL367702A1 PL 367702 A1 PL367702 A1 PL 367702A1 PL 02367702 A PL02367702 A PL 02367702A PL 36770202 A PL36770202 A PL 36770202A PL 367702 A1 PL367702 A1 PL 367702A1
- Authority
- PL
- Poland
- Prior art keywords
- taxane
- cyclin
- combination
- dependent kinase
- kinase
- Prior art date
Links
- 102000003903 Cyclin-dependent kinases Human genes 0.000 title 1
- 108090000266 Cyclin-dependent kinases Proteins 0.000 title 1
- 229940123237 Taxane Drugs 0.000 title 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27794801P | 2001-03-23 | 2001-03-23 | |
| US30269201P | 2001-07-05 | 2001-07-05 | |
| US33491601P | 2001-12-04 | 2001-12-04 | |
| PCT/EP2002/004083 WO2002076484A2 (en) | 2001-03-23 | 2002-03-22 | Combination of a taxane and a cyclin-dependent kinase inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL367702A1 true PL367702A1 (en) | 2005-03-07 |
| PL206118B1 PL206118B1 (en) | 2010-07-30 |
Family
ID=27402954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL367702A PL206118B1 (en) | 2001-03-23 | 2002-03-22 | Combination of a taxane and a cyclin-dependent kinase |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US20020182204A1 (en) |
| EP (1) | EP1372652B1 (en) |
| JP (1) | JP2004521140A (en) |
| KR (1) | KR100879712B1 (en) |
| CN (1) | CN1498107A (en) |
| AR (1) | AR034222A1 (en) |
| AT (1) | ATE395917T1 (en) |
| AU (1) | AU2002312815B2 (en) |
| BR (1) | BR0208221A (en) |
| CA (1) | CA2441441C (en) |
| CY (1) | CY1110449T1 (en) |
| CZ (1) | CZ301423B6 (en) |
| DE (1) | DE60226710D1 (en) |
| DK (1) | DK1372652T3 (en) |
| EA (1) | EA007815B1 (en) |
| ES (1) | ES2305253T3 (en) |
| HR (1) | HRPK20030766B3 (en) |
| HU (1) | HU229258B1 (en) |
| IL (2) | IL158058A0 (en) |
| ME (1) | MEP16408A (en) |
| MX (1) | MXPA03007743A (en) |
| NO (1) | NO332441B1 (en) |
| NZ (1) | NZ527655A (en) |
| PE (1) | PE20020907A1 (en) |
| PL (1) | PL206118B1 (en) |
| PT (1) | PT1372652E (en) |
| RS (1) | RS50681B (en) |
| SI (1) | SI1372652T1 (en) |
| SK (1) | SK287481B6 (en) |
| TW (1) | TWI355935B (en) |
| UY (1) | UY27220A1 (en) |
| WO (1) | WO2002076484A2 (en) |
| ZA (1) | ZA200307381B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003075943A2 (en) * | 2002-03-06 | 2003-09-18 | The Medical Research And Education Trust | Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol |
| AU2003287081A1 (en) * | 2002-10-16 | 2004-05-04 | Ilex Products, Inc. | Clofarabine and taxane chemotherapy combination |
| AU2003276467A1 (en) * | 2002-11-06 | 2004-06-07 | Cyclacel Limited | Combination comprising docetaxel and a cdk inhibitor |
| JP5537035B2 (en) * | 2006-02-10 | 2014-07-02 | ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ | A combination comprising a CDK inhibitor and a growth factor antibody or anti-mitotic agent |
| MX2013005661A (en) * | 2010-11-19 | 2013-09-13 | Piramal Entpr Ltd | PHARMACEUTICAL COMBINATION OF PACLITAXEL AND A CDK INHIBITOR (CYCLINE DEPENDENT KINASE). |
| HRP20191927T1 (en) * | 2011-04-01 | 2020-01-10 | Astrazeneca Ab | THERAPEUTIC TREATMENT |
| PL2785349T5 (en) | 2011-11-30 | 2023-01-30 | Astrazeneca Ab | Combination treatment of cancer |
| AU2013204533B2 (en) | 2012-04-17 | 2017-02-02 | Astrazeneca Ab | Crystalline forms |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2601675B1 (en) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | TAXOL DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| MX9102128A (en) * | 1990-11-23 | 1992-07-08 | Rhone Poulenc Rorer Sa | DERIVATIVES OF TAXANE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM |
| FR2697752B1 (en) * | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Antitumor compositions containing taxane derivatives. |
| WO1997030174A1 (en) * | 1996-02-20 | 1997-08-21 | Sloan-Kettering Institute For Cancer Research | Combinations of pkc inhibitors and therapeutic agents for treating cancers |
-
2002
- 2002-03-21 US US10/101,947 patent/US20020182204A1/en not_active Abandoned
- 2002-03-21 UY UY27220A patent/UY27220A1/en not_active Application Discontinuation
- 2002-03-22 BR BR0208221-7A patent/BR0208221A/en not_active Application Discontinuation
- 2002-03-22 EA EA200301053A patent/EA007815B1/en not_active IP Right Cessation
- 2002-03-22 KR KR1020037012338A patent/KR100879712B1/en not_active Expired - Fee Related
- 2002-03-22 MX MXPA03007743A patent/MXPA03007743A/en active IP Right Grant
- 2002-03-22 DE DE60226710T patent/DE60226710D1/en not_active Expired - Lifetime
- 2002-03-22 SK SK1169-2003A patent/SK287481B6/en not_active IP Right Cessation
- 2002-03-22 WO PCT/EP2002/004083 patent/WO2002076484A2/en not_active Ceased
- 2002-03-22 DK DK02737950T patent/DK1372652T3/en active
- 2002-03-22 HR HR20030766A patent/HRPK20030766B3/en not_active IP Right Cessation
- 2002-03-22 JP JP2002574997A patent/JP2004521140A/en active Pending
- 2002-03-22 HU HU0303589A patent/HU229258B1/en not_active IP Right Cessation
- 2002-03-22 PT PT02737950T patent/PT1372652E/en unknown
- 2002-03-22 EP EP02737950A patent/EP1372652B1/en not_active Expired - Lifetime
- 2002-03-22 CA CA002441441A patent/CA2441441C/en not_active Expired - Fee Related
- 2002-03-22 PE PE2002000230A patent/PE20020907A1/en not_active Application Discontinuation
- 2002-03-22 SI SI200230711T patent/SI1372652T1/en unknown
- 2002-03-22 NZ NZ527655A patent/NZ527655A/en not_active IP Right Cessation
- 2002-03-22 CN CNA028070380A patent/CN1498107A/en active Pending
- 2002-03-22 PL PL367702A patent/PL206118B1/en not_active IP Right Cessation
- 2002-03-22 AT AT02737950T patent/ATE395917T1/en active
- 2002-03-22 AU AU2002312815A patent/AU2002312815B2/en not_active Ceased
- 2002-03-22 IL IL15805802A patent/IL158058A0/en unknown
- 2002-03-22 ME MEP-164/08A patent/MEP16408A/en unknown
- 2002-03-22 ES ES02737950T patent/ES2305253T3/en not_active Expired - Lifetime
- 2002-03-22 TW TW091105567A patent/TWI355935B/en not_active IP Right Cessation
- 2002-03-22 CZ CZ20032551A patent/CZ301423B6/en not_active IP Right Cessation
- 2002-03-22 RS YUP-695/03A patent/RS50681B/en unknown
- 2002-03-22 AR ARP020101061A patent/AR034222A1/en unknown
-
2003
- 2003-09-16 NO NO20034124A patent/NO332441B1/en not_active IP Right Cessation
- 2003-09-22 IL IL158058A patent/IL158058A/en not_active IP Right Cessation
- 2003-09-22 ZA ZA2003/07381A patent/ZA200307381B/en unknown
-
2006
- 2006-01-27 US US11/341,840 patent/US20060128640A1/en not_active Abandoned
-
2008
- 2008-08-11 CY CY20081100843T patent/CY1110449T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03006420A (en) | Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase. | |
| SG111920A1 (en) | Authentication of electronic documents | |
| AU2002332749A1 (en) | Package with integrated inductor and/or capacitor | |
| GB0121789D0 (en) | Electronic paymetn authorisation | |
| IL161384A0 (en) | Bicyclic oxopyridine and oxopyrimidine derivatives | |
| EP1390052A4 (en) | Inhibition of jun kinase | |
| SG100745A1 (en) | Ceramic composition and ceramic capacitor | |
| EP1392317A4 (en) | Substituted 1-benzazepines and derivatives thereof | |
| PL367702A1 (en) | Combination of a taxane and a cyclin-dependent kinase | |
| GB0126889D0 (en) | Compounds and their uses | |
| GB0123657D0 (en) | Worktool | |
| GB2376928B (en) | Personal hoverplane having four tiltmotors | |
| HUP0500734A3 (en) | Use of 2-alkoxyphenyl-substituted imidazotriazinones | |
| IL158239A0 (en) | Zonisamide intermediate and synthesis | |
| PL367639A1 (en) | Novel heterocyclic compound and medicinal use thereof | |
| EP1381061A4 (en) | Inductance element and case | |
| GB0115234D0 (en) | Electronic authorisation | |
| HUP0401162A3 (en) | Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives | |
| IL161608A0 (en) | Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines | |
| EP1421101A4 (en) | P-glycoproteins and uses thereof | |
| IL156839A0 (en) | Use of chromanes | |
| EP1392460A4 (en) | Hydrogenfluorides of aminosilanols and their use | |
| ZA200305379B (en) | Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase. | |
| HU0104370D0 (en) | Honeyed schnaps of oerseg | |
| TW573751U (en) | Structure capable of preventing jaming |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Decisions on the lapse of the protection rights |
Effective date: 20140322 |